Search research articles
Contact Us
Filters
Showing results (221-230 of 298) with videos related to
Page
of 30
Sort By:
Blood Cancer Journal
|
August 29, 2025
Treatment outcomes and CNS relapse risk in patients with primary cutaneous DLBCL, leg-type in the rituximab era
Giulio Cassanello, Esther Drill, Annie Qiu, et al.
British Journal of Haematology
|
January 21, 2010
High-dose chemo-radiotherapy for relapsed or refractory Hodgkin lymphoma and the significance of pre-transplant functional imaging
Craig H Moskowitz, Joachim Yahalom, Andrew D Zelenetz, et al.
JAMA Cardiology
|
May 22, 2024
Transcatheter or Surgical Replacement for Failed Bioprosthetic Aortic Valves
Jessica H Tran, Shinobu Itagaki, Qi Zeng, et al.
Hepatology (Baltimore, Md.)
|
July 29, 2014
Costs of telaprevir-based triple therapy for hepatitis C: $189,000 per sustained virological response
Kian Bichoupan, Valerie Martel-Laferriere, David Sachs, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
November 6, 2017
A multi-institutional cohort study confirming the risks of Clostridium difficile infection associated with prolonged antibiotic prophylaxis
Katherine A Kirkwood, Brian C Gulack, Alexander Iribarne, et al.
Leukemia & Lymphoma
|
March 29, 2021
Outcomes of adult T-Cell leukemia/lymphoma with allogeneic stem cell transplantation: single-institution experience
Zachary D Epstein-Peterson, Nivetha Ganesan, Juliet N Barker, et al.
American Journal of Hematology
|
May 26, 2016
Clinical characteristics and outcomes of patients with Hodgkin lymphoma with central nervous system involvement: An international multicenter collaboration
Chan Y Cheah, Paul J Bröckelmann, Dai Chihara, et al.
The Annals of Thoracic Surgery
|
April 24, 1999
The REMATCH trial: rationale, design, and end points. Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure
E A Rose, A J Moskowitz, M Packer, et al.
Blood
|
May 3, 2014
Pancreatitis in patients treated with brentuximab vedotin: a previously unrecognized serious adverse event
Mitul D Gandhi, Andrew M Evens, Timothy S Fenske, et al.
Blood Advances
|
March 26, 2024
Nivolumab plus brentuximab vedotin for relapsed/refractory peripheral T-cell lymphoma and cutaneous T-cell lymphoma
Pier Luigi Zinzani, Gilles Salles, Alison J Moskowitz, et al.
Page
of 30
Search research articles
Search
Showing results (221-230 of 298) with videos related to
Sort By:
Page
of 30
Blood Cancer Journal
|
August 29, 2025
Treatment outcomes and CNS relapse risk in patients with primary cutaneous DLBCL, leg-type in the rituximab era
Giulio Cassanello, Esther Drill, Annie Qiu, et al.
British Journal of Haematology
|
January 21, 2010
High-dose chemo-radiotherapy for relapsed or refractory Hodgkin lymphoma and the significance of pre-transplant functional imaging
Craig H Moskowitz, Joachim Yahalom, Andrew D Zelenetz, et al.
JAMA Cardiology
|
May 22, 2024
Transcatheter or Surgical Replacement for Failed Bioprosthetic Aortic Valves
Jessica H Tran, Shinobu Itagaki, Qi Zeng, et al.
Hepatology (Baltimore, Md.)
|
July 29, 2014
Costs of telaprevir-based triple therapy for hepatitis C: $189,000 per sustained virological response
Kian Bichoupan, Valerie Martel-Laferriere, David Sachs, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
November 6, 2017
A multi-institutional cohort study confirming the risks of Clostridium difficile infection associated with prolonged antibiotic prophylaxis
Katherine A Kirkwood, Brian C Gulack, Alexander Iribarne, et al.
Leukemia & Lymphoma
|
March 29, 2021
Outcomes of adult T-Cell leukemia/lymphoma with allogeneic stem cell transplantation: single-institution experience
Zachary D Epstein-Peterson, Nivetha Ganesan, Juliet N Barker, et al.
American Journal of Hematology
|
May 26, 2016
Clinical characteristics and outcomes of patients with Hodgkin lymphoma with central nervous system involvement: An international multicenter collaboration
Chan Y Cheah, Paul J Bröckelmann, Dai Chihara, et al.
The Annals of Thoracic Surgery
|
April 24, 1999
The REMATCH trial: rationale, design, and end points. Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure
E A Rose, A J Moskowitz, M Packer, et al.
Blood
|
May 3, 2014
Pancreatitis in patients treated with brentuximab vedotin: a previously unrecognized serious adverse event
Mitul D Gandhi, Andrew M Evens, Timothy S Fenske, et al.
Blood Advances
|
March 26, 2024
Nivolumab plus brentuximab vedotin for relapsed/refractory peripheral T-cell lymphoma and cutaneous T-cell lymphoma
Pier Luigi Zinzani, Gilles Salles, Alison J Moskowitz, et al.
Page
of 30